Dymista® is suitable for long-term use
For perennial allergic rhinitis patients to get the full therapeutic benefit, regular use of treatment is essential. With Dymista®, the duration of treatment should correspond to the period of allergenic exposure and Dymista® is suitable for long-term use'
A 52-week open-label study showed Dymista® has a large therapeutic spectrum, covering not only seasonal allergic rhinitis but also perennial allergic rhinitis with consistent superiority over an intranasal certicostemid2
Fluticasone propionate when delivered in a nasal spray exerts a topical effect without systemic effects due to low systemic bioavailabitlity3
Further Your Understanding
Click on one of the below links to discover more information about Dymista®, including Flow to use Dymista®, guidelines, clinical papers and request materials.
Impact of Rhinitis
- Dymista, Summary of Product Characteristics
- Price D et al. A New Therapy (MP29-02) Is Effective for the Long-Term Treatment, Chronic Rhinilis. J Investig Allergol Clin Immunol 2013 Vol. 23(7): 495-503.
- Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; Frist edition 2007). Clin Exp Allergy. 2017; 47:856-889